6505--Montelukast 10mg Tablet
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
NAC PHARMACEUTICALS (36E797)
Contract Value
Not provided
Codes & Classification
Solicitation Number
36E79725R0061
NAICS
325412 - Pharmaceutical Preparation Manufacturing
Classification Code
6505
Additional Details
Documents1
The Department of Veterans Affairs (VA), through its National Acquisition Center (NAC) Pharmaceuticals office, has issued an award notice for the procurement of Montelukast 10mg tablets. This acquisition falls under NAICS code 325412, which pertains to Pharmaceutical Preparation Manufacturing, and is classified with Product Service Code 6505, indicating a focus on pharmaceutical products.
The primary objective of this procurement is to secure a reliable supply of Montelukast 10mg tablets, a medication commonly used in the management of asthma and allergic rhinitis, for distribution within the VA healthcare system. The intended outcome is to ensure that VA medical facilities have consistent access to this essential medication, thereby supporting the health and well-being of veterans nationwide.
The contracting entity responsible for this award is the NAC PHARMACEUTICALS office (organization key: 500000036), operating as a federal office within the Department of Veterans Affairs. The procurement activity is managed by Kenneth Lay, who serves as the primary contact for this notice. Interested parties may reach Mr. Lay via email at [email protected] or by phone at (708) 786-4879 for further information or clarification regarding the award.
This award notice is currently active and was posted on September 1, 2026. The opportunity is listed on SAM.gov under Opportunity ID a7ad94e6af8c4a168c6a092a60e00301, where additional details and one attachment are available for review. The procurement is sourced through BIDMATCH_SAM, indicating that it follows federal acquisition protocols.
While the notice does not specify set-aside requirements or special considerations, contractors should note that the scope is limited to the manufacturing and supply of Montelukast 10mg tablets in accordance with federal standards and VA requirements. The contract is expected to remain consistent in its core deliverable—the provision of Montelukast 10mg tablets—throughout its lifecycle.
Contractors with capabilities in pharmaceutical preparation manufacturing, particularly those experienced in supplying medications to federal agencies, may find this opportunity aligns well with their expertise. The procurement supports a critical need within the VA healthcare system and offers a stable, ongoing requirement for qualified suppliers.